RxDoctor Payments DataLook up a doctor →

James Campbell, DO

Family Medicine · Broken Arrow, OKNPI 1720091077

Payments from drug & device makers

$35,053in general payments, 2019–2025

Across 1,344 payments — averaging $26.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$4K
  • AbbVie$3K
  • Amgen$2K
  • GSK$2K
  • Bayer$2K
  • Novo Nordisk$2K
  • plus $21K from 54 others

What the payments were for

  • Travel & lodging$320%
  • Food & beverage$34,74699%
  • Education$2751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca89$3,626
AbbVie(2 entities)203$3,367
Amgen(2 entities)48$1,965
GSK45$1,697
Bayer54$1,626
Novo Nordisk48$1,577
Boehringer Ingelheim48$1,385
Pfizer75$1,298
Johnson & Johnson23$1,266
Lilly USA, LLC54$1,250
Vanda Pharmaceuticals Inc.36$1,006
Teva Pharmaceuticals USA, Inc.11$996
Amarin Pharma, Inc.40$841
Merck41$811
Corium, LLC54$753
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)10$564
Novartis27$562
Antares Pharma, Inc.26$539
Noven Therapeutics, LLC32$538
Takeda Pharmaceuticals U.S.A., Inc.33$533
Otsuka America Pharmaceutical, Inc.37$525
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$522
Abbott16$511
Biohaven Pharmaceutical Holding Company Ltd.16$462
Astellas Pharma US Inc21$458
Intra-sana Laboratories12$455
Boston Scientific12$398
Kowa Pharmaceuticals America, Inc.26$365
Arbor Pharmaceuticals, Inc.25$329
Sunovion Pharmaceuticals Inc.13$327
Azurity Pharmaceuticals, Inc.16$282
Daiichi Sankyo Inc.3$278
Mannkind Corporation4$265
Abiomed2$236
Kyowa Kirin, Inc.8$232
Nestle Healthcare Nutrition Inc.7$225
Phathom Pharmaceuticals, Inc.7$218
Dexcom, Inc.2$214
Alk-abello, Inc5$205
Clarus Therapeutics Inc.7$192
Exact Sciences6$191
Idorsia Pharmaceuticals US Inc5$176
Almatica Pharma LLC10$167
Sanofi-aventis U.S. LLC3$155
Jazz Pharmaceuticals Inc.3$147
Galderma Laboratories, L.p.7$126
Supernus Pharmaceuticals, Inc.7$126
Biohaven Pharmaceuticals, Inc.4$125
Indivior Inc.1$124
Esperion Therapeutics, Inc.1$124
Noven Pharmaceuticals, Inc.1$111
Pulmonx Corporation1$110
Sumitomo Pharma America, Inc.14$109
Biogen4$66
Halozyme Inc3$53
Eisai Inc.4$53
Vertical Pharmaceuticals, LLC2$29
Revance Therapeutics, Inc.1$25
Nevro Corp.1$22
Paratek Pharmaceuticals, Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,053 in reported general payments places this provider in the 95th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$96,017
Medicare patients
198
Services billed
1,416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide126$127,321
EliquisApixaban130$86,276
JardianceEmpagliflozin57$66,866
Trelegy ElliptaFluticasone/Umeclidin/Vilanter84$59,289
MounjaroTirzepatide39$39,868
TrulicityDulaglutide32$35,581
XareltoRivaroxaban40$33,209
FarxigaDapagliflozin Propanediol26$30,838
VraylarCariprazine Hcl16$30,247
VascepaIcosapent Ethyl31$24,884
Breztri AerosphereBudesonide/Glycopyr/Formoterol30$22,125
RybelsusSemaglutide19$19,969
KerendiaFinerenone12$11,123
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen312$9,935
EntrestoSacubitril/Valsartan29$9,403

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,577$147,290145 claims
PfizerEliquis$1,298$86,276130 claims
Lilly USA, LLCMounjaro, Trulicity$1,250$75,44871 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$1,697$71,795116 claims
Boehringer IngelheimJardiance$1,385$66,86657 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$3,626$55,85767 claims
Johnson & JohnsonXarelto$1,266$33,20940 claims
AbbVieVraylar$3,367$30,24716 claims
BayerKerendia$1,626$11,12312 claims
NovartisEntresto$562$9,40329 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Broken Arrow

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →